Robert Thomas Fremeau Jr. - 25 Oct 2021 Form 3 Insider Report for Vyant Bio, Inc.

Role: Chief Scientific Officer
Signature: /s/ Andrew LaFrence, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 25 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 17 Nov 2021, 16:00:50 UTC
Next filing: 17 Nov 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney